TimeTeller pitches saliva-based body-clock test to time cancer treatment

German startup TimeTeller, led by CEO Angela Relógio, presented its saliva-based circadian profiling kit at the TechCrunch Disrupt Startup Battlefield in San Francisco on October 14, 2026. The test profiles core clock gene expression to time cancer therapy to each patient's internal clock, aiming to cut side effects and improve outcomes.